Drug Shortage Report for M-RANITIDINE
Report ID | 127450 |
Drug Identification Number | 02473534 |
Brand name | M-RANITIDINE |
Common or Proper name | M-Ranitidine |
Company Name | MANTRA PHARMA INC |
Market Status | CANCELLED POST MARKET |
Active Ingredient(s) | RANITIDINE |
Strength(s) | 150MG |
Dosage form(s) | TABLET |
Route of administration | ORAL ORAL |
Packaging size | 500 |
ATC code | A02BA |
ATC description | DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD) |
Reason for shortage | Delay in shipping of the drug. |
Anticipated start date | |
Actual start date | 2020-10-28 |
Estimated end date | Unknown |
Actual end date | |
Shortage status | Actual shortage |
Updated date | 2021-07-30 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 1000 RUE DU LUX SUITE 201 BROSSARD, QUEBEC CANADA J4Y 0E3 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.